Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: Biological and biochemical characterization

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 1078-1088

  Dumont, Francis J ^a   Ok, Hyun ^a   Lin, Shirley ^a   Kastner, Carolyn A ^a   Cryan, John ^a   Martin, Mary M ^a   Wiederrecht, Gregory ^a   Staruch, Mary Jo ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; L 683590; L 688617; LONOMYCIN; NIGERICIN; TACROLIMUS;

ANIMAL; ARTICLE; BINDING COMPETITION; C57BL MOUSE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; METABOLISM; MOUSE; T LYMPHOCYTE;

ANIMALS; BINDING, COMPETITIVE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; NIGERICIN; T-LYMPHOCYTES; TACROLIMUS;

EID: 0030111240     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ALDAPE, R A., FUTER, O., DECENZO, M. T., JARRETT, B. P., MURCKO, M. A. AND LIVINGSTON, D. J.: Charged surface residues of FKBP12 participate in formation of the FKBP12-FK-506-calcineurin complex. J. Biol Chem. 267: 16029-16031, 1992.
2. ARUNLAKSHANA, O AND SCHILD, H. O.: Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58, 1959.
3. ASAMI, M., KUNO, T., MUKAI, H. AND TANAKA, C.: Detection of the FK506-FKBP-calcineurin complex by a simple binding assay. Biochem. Biophys. Res. Com. 192: 1388-1394, 1993.
4. BECKER, J. W., ROTONDA, J., MCKEEVER, B. M., CHAN, H. K., MARCY, A I., WIEDERRECHT, G., HERMES, J. AND SPRINGER, J. P.: FK506-binding protein: Three-dimensional structure of the complex with the antagonist L-685,818. J. Biol. Chem. 268: 11335-11339, 1993.
5. BRUNNER, T., MOGIL, R. J., LAFACE, D., YOO, N. J., MAHBOUDI, A., ECHEVERRI, F., MARTIN, S. J., FORCE, W. R., LYNCH, D. H., WARE, C. F AND GREEN, D. R.: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosia in T cell hybridomas. Nature 373: 441-444, 1995.
6. CLIPSTONE, N. A. AND CRABTREE, G. R.: Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695-697, 1992.
7. DHEIN, J., WALCZAK, H , BAUMIER, C., DEBATIN, K. M. AND KRAMMER, P. H.: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438-441, 1995
8. DUMONT, F. J.: Cyclosporin A and tacrolimus (FK-506): Immunosuppression through immunophilin-dependent inhibition of calcineurin function. In Principles of drug development in transplantation and autoimmunity, ed. by R. Lieberman and A. Mukherjee, pp. 175-205, R. G. Landes Co, Austin, TX, 1996.
9. DUMONT, F. J., KASTNER, C., IACCOVONE, F AND FISCHER, P.. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T lymphocytes. J. Pharmacol. Exp. Ther. 268: 32-41, 1994
10. DUMONT, F. J., MELINO, M. R., STARUCH, M. J., KOPRAK, S. L., FISCHER, P. A. AND SIGAL, N. H.: The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J. Immunol. 144: 1418-1424, 1990a.
11. DUMONT, F. J., STARUCH, M. J., KOPRAK, S. L., MELINO, M. R. AND SIGAL, N. H.: Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144: 251-258, 1990b.
12. DUMONT, F. J., STARUCH, M. J., KOPRAK, S. L., SIEKIERKA, J. J., LIN, S., HARRISON, R., SEWELL, T., KINDT, V. M., BEATTIE, T., WYVHATT, M AND SIGAL, N H.: The immunosuppressive and toxic effects of FK-506 are mechanistically related: Pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. 176: 751-760, 1992.
13. FRETZ, H., ALBERS, M. W., GALAT, A., STANDAERT, R. F., LANE, W. S., BURAKOFF, S., BIERER, B. E. AND SCHREIBER, S. L.: Rapamycin and FK506 binding proteins (immunophilins). J. Am. Chem. Soc. 113: 1409-1411, 1991.
14. FRUMAN, D. A., KLEE, C. B., BIERER, B. E. AND BURAKOFF, S. J.: Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. NatL Acad. Sci. USA 89: 3686-3690, 1992a.
15. FRUMAN, D. A., MATHER, P. E., BURAKOFF, S. J. AND BIERER, B. E.: Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Eur. J. Immunol. 22: 2513-2517, 1992b.
16. GAJEWSKI T. F., FIELDS P. AND FITCH F. W.: Induction of the increased Fyn kinase activity in anergic T helper type 1 clones requires calcium and protein synthesis and is sensitive to cyclosporin A. Eur. J. Immunol. 25:1836-1842, 1995.
17. GOULET, M. T , RUPPRECHT, K. M., SINCLAIR, P. J., WYVRATT, M. J. AND PARSONS, W. H.: The medicinal chemistry of FK-506. Perspect. Drug Discov. Design 2: 145-162, 1994.
18. GREEN, D. R , BISSONNETTE, R. P., GLYNN, J. M. AND SHI, Y.: Activation-induced apoptosis in lymphoid cells. Semin. Immunol. 4: 379-388, 1992.
19. GRIFFITH, J. P., KIM, J. L., KIM, E. E., SINTCHAK, M. D., THOMSON, J. A., FITZGIBBON, M. J., FLEMING, M. A., FLEMING, M. A., CARON, P. R., HSIAO, K. AND NAVIA, M. A.: X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 82: 507-522, 1995.
20. HANDSCHUMACHER, R. E., HARDING, M. W., RICE, J., DRUGGE, R. J. AND SPEICHER, D. W.: Cyclophilin. A specific cytosolic binding protein for cyclosporin A. Science 226: 544-547, 1984
21. HATANAKA, H., KINO, T., MIYATA, S., INAMURA, N., KURODA, A., GOTO, T., TANAKA, H. AND OKUHARA, M.: FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physicochemical and biological characteristics. J. Antibiot. (Tokyo) 41: 1592-1601, 1988.
22. JENKINS, M. K., PARDOLL, D. M , MIZUGUCHI, J., CHUSED, T. M. AND SCHWARTZ, R. H.: Molecular events in the induction of a non-responsive state in interleukin-2 producing helper T lymphocyte clones. Proc. Natl. Acad. Sci USA 84: 5409-5413, 1987.
23. LAING, T. J. AND WEISS, A.: Evidence for IL-2 independent proliferation in human T cells. J. Immunol. 140: 1056-1062, 1988.
24. LIU, J , ALBERS, M. W., WANDLESS, T. J., LUAN, S., ALBERG, D. G., BELSHAW, P. J., COHEN, P., MACKINTOSH, C., KLEE, C. B. AND SCHREIBER, S. L.: Inhibition of T cell signaling by immunophihn-ligand complexes correlates with loss of calcineurin phosphatase activity Biochemistry 31: 3896-3901, 1992.
25. LIU, J., FARMER, J. D., LANE, W. S., FRIEDMAN, J., WEISSMAN, I. AND SCHREIBER, S. L.: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815, 1991.
26. LYSON, T., ERMEL, L. D , BELSHAW, P. J., ALBERG, D. G., SCHREIBER, S. L AND VICTOR, R G.: Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T cell signaling. Circ. Res. 73: 596-602, 1993.
27. MARRACK, P., HANNUM, C., HARRIS, M., HASKINS, K., KUBO, R., PIGEON, M., SHIMONKEVITZ, R., WHITE, J. AND KAPPLER, J.: Antigen-specific major histocompatibility complex-restricted T cell receptors. Immunol. Rev. 76: 131, 1983.
28. MARTIN, M. M. AND WIEDERRECHT, G. J.: A filter-based, 96-well microtiter plate calcineurin phosphatase assay. Immunomethods, in press, 1996.
29. MATTILA, P. S., ULLMAN, K. S., FIERING, S., EMMEL, E. A., MCCUTCHEON, M., CRABTREE, G. R AND HERZENBERG, L. A.. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9: 4425-4433, 1990.
30. MCDIARMID, S. V., BUSUTTIL, R. W , ASCHER, N. L., BURDICK, J., D'ALESSANDRO, A. M., ESQUIVEL, C., KALAYOGLU, M., KLEIN, A. S., MARSH, J. W., MILLER, C. M., SCHWARTZ, M. E., SHO, B. W. AND S. O., S. K.: FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pedriatic liver transplantation Tansplantation 59: 530-536, 1995.
31. 2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142:4085-4092, 1989.
32. MUKAI, H., KUNO, T., CHANG, C. D , LANE, B., LULY, J. R. AND TANAKA, C.: FKBP12-FK-506 complex inhibits phosphatase activity of two mammalian isoforms of calcineurin irrespective of their substrates or activation mechanisms. J. Biochem. 113: 292-298, 1993.
33. NAGATA, S AND GOLSTEIN, P.: The Fas death factor. Science 267: 1449-1456, 1995.
34. NORTHROP, J. P., H. O , S. N., CHEN, L., THOMAS, D. J., TIMMERMAN, L. A., NOLAN, G. P., ADMON, A. AND CRABTREE, G. R.: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497-502, 1994.
35. O'KEEFE, S. J., TAMURA, J., KINCAID, R. L., TOCCI, M. J. AND O'NEIL, E.: FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357: 692-694, 1992.
36. ORGAN, H. M., HOLMES, M. A., PISANO, J. M., STARUCH, M. J., WYVRATT, M. J., DUMONT, F. J. AND SINCLAIR, P. J.: Novel derivatives at the C21 position of the FK-506 macrocycle. Bioorganic Med. Chem. Lett. 3: 657-662, 1993.
37. RAO, A.: NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15: 274-281, 1994.
38. SABATINI, D. M., ERDJUMENT-BROMAGE, H., LUI, M., TEMPST, P. AND SNYDER, S. H.: RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78: 35-43, 1994.
39. SABERS, C., MARTIN, M. M., BRUNN, G. J., WILLIAMS, J. M., DUMONT, F. J., WIEDERRECHT, G. AND ABRAHAM, R. T.: Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270: 815-822, 1995.
40. SALITURO, G. M., ZINK, D. L., DAHL, D. L., NIELSEN, A., J. W. U., HUANG, L. E., KASTNER, C. AND DUMONT, F. J.: Meridamyein: A novel non-immunosuppressive FKBP12 ligand from Streptomyceshygroscopicus. Tetrahedron Lett. 36: 997-1000, 1995.
41. SCHREIBER, S. L.: Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283-287, 1991.
42. SEHGAL, S. N., MOLNAR-KIMBER, K., OCAIN, T. D. AND WEICHMAN, B. W.: Rapamycin: a novel immunosuppressive macrolide. Med. Res. Rev. 14: 1-22, 1994.
43. SHAPIRO, R., JORDAN, M. L., SCANTLEBURY, V. P., VIVAS, C., FUNG, J. J., MCCAULEY, J., RANDHAWA, P., DEMETRIS, A. J., IRISH, W., MITCHELL, S., HAKALA, T. R., SIMMONS, R. L. AND STARZL, T. E.. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 59: 485-490, 1995.
44. SIEKIERKA, J. J., HUNG, S. H., POE, M., LIN, C. S. AND SIGAL, N. H.: A cytosolic binding protein for the immunosuppressant FK-506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341: 755-757, 1989.
45. SIGAL, N. H. AND DUMONT, F. J.: Cyclosporin A, FK-506 and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10: 519-560, 1992.
46. STARUCH, M. J., SIGAL, N. H. AND DUMONT, F. J.: Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T cell apoptosis. Int. J. Immunopharmacol. 13: 677-685, 1991.
47. THOMSON, A. W., CARROLL, P. B., MCCAULEY, J., WOO, J., ABU-ELMAGD, K., STARZL, T. E. AND THIEL, D. H. V.: FK506: A novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin. Immunopathol. 14: 323-344, 1993.
48. TOCCI, M. J., MATKOVICH, D. A., COLLIER, K. A., KWOK, P., DUMONT, F., LIN, C S., DEGUDICIBUS, S., SIEKIERKA, J J., CHIN, J. AND HOTCHINSON, N. I.: The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143: 718-726, 1989.
49. VAN DUYNE, G. D., STANDAERT, R. F., KARPLUS, P. A., SCHREIBER, S. L. AND CLARDY, J.: Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 252: 839-842, 1991.
50. WIEDERRECHT, G., HUNG, S., CHAN, H. K., MARCY, A., MARTIN, M., CALAYCAY, J., BOULTON, D., SIGAL, N., KINCAID, R. L. AND SIEKIERKA, J. J.: Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex. J. Biol. Chem. 267: 21753-21760, 1992.
51. YANG, D., ROSEN, M. K. AND SCHREIBER, S. L.: A composite FKBP-12-FK-506 surface that contacts calcineurin. J. Am. Chem. Soc. 115: 819-820, 1993.